A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Status:
Completed
Trial end date:
2017-07-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of ABT-450/r/ABT-267 with or
without ABT-333 and with or without ribavirin (RBV) in adult liver or renal transplant
recipients with hepatitis C virus (HCV) genotype 1 or 4 (GT1 or GT4) infection.